Pursuant to Regulation 30 and 33 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 We hereby submit the outcome of the meeting together ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Riddhi Siddhi Gluco Biols Limited met on November 13, 2025 and approved unaudited standalone and consolidated financial results for Q2 and H1 FY26 (quarter and half year ended September 30, 2025), along with the Limited Review Reports by M/s Batliboi & Purohit. Standalone revenue from operations jumped sharply to ₹17,070.60 lakhs in H1 FY26 (vs ₹4,278.93 lakhs in H1 FY25) driven by a much higher trading business contribution, while standalone profit after tax dipped to ₹4,226.93 lakhs (vs ₹5,750.67 lakhs). On a consolidated basis, H1 FY26 profit after tax from continuing operations was ₹2,493.69 lakhs, with an additional loss of ₹314.40 lakhs from the discontinued Paper Division of subsidiary Shree Rama Newsprint Limited. The Board also noted the Integrated Filing (Governance) Report for the period.
Shareholders should note the large contingent tax liability of ₹308 lakhs pending before ITAT, ongoing SEBI matters (next hearing November 20, 2025) on penalty and Minimum Public Shareholding compliance, and the continued drag from the discontinued Paper Division of the subsidiary which had a ₹6,956.48 lakhs impairment booked earlier. The spike in trading-based revenue and a fall in core profitability may draw investor attention.